URL has been copied successfully!
On Thursday, the Senate health committee met with Heidi Overton, nominee for commissioner of the Food and Drug Administration. When asked about her views on mifepristone, a key abortion medication, Overton danced around the issue.
As the CEO of Reproductive Futures, a legal organization advocating for reproductive rights, I am deeply concerned. Overton’s anti-abortion views are crystal clear. As FDA commissioner, she would have a chance to implement them and do serious harm.
Please follow us:
